Peter Pizzo

ControlRad, which is focused on reducing unnecessary radiation exposure during fluoroscopically guided procedures (FGP), has announced several additions to its leadership team. Joining are Peter Pizzo as chief financial officer, Amy Lazarus as vice president of USA operations, Joe Ross as vice president of marketing, and Sean Finnerty and Tim Hein as area vice presidents of sales. A press release reports that the industry veterans bring considerable experience leading businesses and introducing new products in the medical device industry.

The press release adds that ControlRad Trace is a recently FDA-cleared technology that can be integrated into existing mobile C-arms to reduce radiation in any FGP. It is designed to reduce radiation exposure by a minimum of 50% and up to 89%, protecting patients and medical staff without compromising image quality or workflow.

The new appointments include:

  • Peter Pizzo—chief financial officer: Pizzo has more than 25 years of experience in senior financial roles with venture-backed and public life science companies.
  • Amy Lazarus—vice president of USA Operations: Lazarus has broad industry experience and a reputation for developing operational infrastructure and processes, building teams, and running P&Ls.
  • Joe Ross—vice president of marketing: Ross has worked for nearly 25 years in the medical device industry, holding senior leadership positions at both private and public companies.

The other appointments are Sean Finnerty as area vice president of sales (East) and Timothy Hein, area vice president of sales (West).

Guillaume Bailliard, ControlRad CEO, says: “2019 was a significant year for ControlRad, with FDA clearance and initial installations of our first product. The wealth of experience that Peter, Amy, Joe, Sean and Tim bring in introducing new products to the market will be invaluable as we ramp up commercialisation for ControlRad Trace in 2020.”